EP1687026

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITING IL-17 ACTIVITY

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    16.11.2004
  • EP published:
    14.5.2008
  • EP application number:
    04798568.4
  • Max expiry date:
    15.11.2024
  • Title:
    METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITING IL-17 ACTIVITY

Timeline

Today
16.11.2004EP application
14.5.2008EP Publication

Owner

  • Name:
    UCB Pharma, S.A.
  • Address:
    Allée de La Recherche 60, 1070, Brussels, BE

Inventor

  • Name:
    CHRISTIE, Mark Ian,Celltech R & D Limited
  • Address:
    Slough,Berkshire SL1 3WE, GB
  • Name:
    MEAD, Richard James,Celltech R & D Limited
  • Address:
    Slough,Berkshire SL1 3WE, GB
  • Name:
    ROBINSON, Martyn Kim,Celltech R & D Limited
  • Address:
    Slough,Berkshire SL1 3WE, GB
  • Name:
    RAPECKI, Stephen Edward,Celltech R & D Limited
  • Address:
    Slough,Berkshire SL1 3WE, GB

Priority

  • Number:
    0327181
  • Date:
    21.11.2003
  • Country:
    GB
  • Number:
    0417115
  • Date:
    30.7.2004
  • Country:
    GB

Upload documents